Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alex Boussioutas

Showing results (41-50 of 115) with videos related to

Pageof 12
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 25, 2014
A signature predicting poor prognosis in gastric and ovarian cancer represents a coordinated macrophage and stromal responseRita A Busuttil, Joshy George, Richard W Tothill, et al.
Journal of Clinical Medicine|October 27, 2022
Therapeutic Drug Monitoring of Subcutaneous Infliximab in Inflammatory Bowel Disease-Understanding Pharmacokinetics and Exposure Response Relationships in a New Era of Subcutaneous BiologicsRobert D Little, Mark G Ward, Emily Wright, et al.
Alimentary Pharmacology & Therapeutics|March 28, 2022
Toward transmural healing: Sonographic healing is associated with improved long-term outcomes in patients with Crohn's diseaseRose Vaughan, Douglas Tjandra, Ashwin Patwardhan, et al.
Contemporary Clinical Trials Communications|February 28, 2023
Can butyrate prevent colon cancer? The AusFAP study: A randomised, crossover clinical trialJulie Clarke, Alex Boussioutas, Brooke Flanders, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 3, 2019
A systematic review of risk-reducing cancer surgery outcomes for hereditary cancer syndromesOliver Peacock, Peadar S Waters, Jaime Otero de Pablos, et al.
Cancer Causes & Control : CCC|September 27, 2012
Screening practices of Australian men and women categorized as "at or slightly above average risk" of colorectal cancerDriss Ait Ouakrim, Trevor Lockett, Alex Boussioutas, et al.
Cancer Prevention Research (Philadelphia, Pa.)|October 28, 2011
Screening practices of unaffected people at familial risk of colorectal cancerDriss Ait Ouakrim, Alex Boussioutas, Trevor Lockett, et al.
International Journal of Cancer|April 27, 2024
Associations between pathological features and risk of metachronous colorectal cancerYe Zhang, Aung Ko Win, Enes Makalic, et al.
The British Journal of Nutrition|July 15, 2022
Diet and risk of Barrett's oesophagus: Melbourne collaborative cohort studySabrina E Wang, Allison Hodge, S Ghazaleh Dashti, et al.
Egastroenterology|February 13, 2025
Pathogenesis and precision medicine for predicting response in inflammatory bowel disease: advances and future directionsRobert D Little, Thisun Jayawardana, Sabrina Koentgen, et al.
Pageof 12

Showing results (41-50 of 115) with videos related to

Sort By:
Pageof 12
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 25, 2014
A signature predicting poor prognosis in gastric and ovarian cancer represents a coordinated macrophage and stromal responseRita A Busuttil, Joshy George, Richard W Tothill, et al.
Journal of Clinical Medicine|October 27, 2022
Therapeutic Drug Monitoring of Subcutaneous Infliximab in Inflammatory Bowel Disease-Understanding Pharmacokinetics and Exposure Response Relationships in a New Era of Subcutaneous BiologicsRobert D Little, Mark G Ward, Emily Wright, et al.
Alimentary Pharmacology & Therapeutics|March 28, 2022
Toward transmural healing: Sonographic healing is associated with improved long-term outcomes in patients with Crohn's diseaseRose Vaughan, Douglas Tjandra, Ashwin Patwardhan, et al.
Contemporary Clinical Trials Communications|February 28, 2023
Can butyrate prevent colon cancer? The AusFAP study: A randomised, crossover clinical trialJulie Clarke, Alex Boussioutas, Brooke Flanders, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 3, 2019
A systematic review of risk-reducing cancer surgery outcomes for hereditary cancer syndromesOliver Peacock, Peadar S Waters, Jaime Otero de Pablos, et al.
Cancer Causes & Control : CCC|September 27, 2012
Screening practices of Australian men and women categorized as "at or slightly above average risk" of colorectal cancerDriss Ait Ouakrim, Trevor Lockett, Alex Boussioutas, et al.
Cancer Prevention Research (Philadelphia, Pa.)|October 28, 2011
Screening practices of unaffected people at familial risk of colorectal cancerDriss Ait Ouakrim, Alex Boussioutas, Trevor Lockett, et al.
International Journal of Cancer|April 27, 2024
Associations between pathological features and risk of metachronous colorectal cancerYe Zhang, Aung Ko Win, Enes Makalic, et al.
The British Journal of Nutrition|July 15, 2022
Diet and risk of Barrett's oesophagus: Melbourne collaborative cohort studySabrina E Wang, Allison Hodge, S Ghazaleh Dashti, et al.
Egastroenterology|February 13, 2025
Pathogenesis and precision medicine for predicting response in inflammatory bowel disease: advances and future directionsRobert D Little, Thisun Jayawardana, Sabrina Koentgen, et al.
Pageof 12